NCT04119713View on ClinicalTrials.gov

Autoimmunity After Checkpoint Blockade

RecruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

February 24, 2020

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

AutoimmunityCancerImmunotoxicityOncology

Trial Locations (1)

19104

RECRUITING

University of Pennsylvania - Abramson Cancer Center, Philadelphia

All Listed Sponsors

lead

University of Pennsylvania

OTHER